Literature DB >> 7944926

Assistive technology: problems and policy alternatives.

B L O'Day1, P J Corcoran.   

Abstract

Assistive technology (AT), defined as any device or product system that increases the physical functioning or independence of persons with disabilities, is transforming the way disabled Americans live and work. Numerous studies show increases in independence, employment, and life satisfaction; yet, the acquisition of AT presents many problems for disabled persons, such as lack of funds to purchase AT, no centralized information and evaluation system, fraud and abuse by some providers, and denials of needed equipment by third-party payers. The proposed Health Security Act could provide a potential mechanism to address these problems, but whether AT should be covered under the Act has received little national attention. In this article we document the need and current funding alternatives for AT, and suggests possible short and long-range strategies to make AT more available for individuals with disabilities.

Entities:  

Mesh:

Year:  1994        PMID: 7944926     DOI: 10.1016/0003-9993(94)90096-5

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  The accuracy of new wheelchair users' predictions about their future wheelchair use.

Authors:  Helen Hoenig; Patricia Griffiths; Shanti Ganesh; Kevin Caves; Frances Harris
Journal:  Am J Phys Med Rehabil       Date:  2012-06       Impact factor: 2.159

2.  The organization and financing of health services for persons with disabilities.

Authors:  Gerben Dejong; Susan E Palsbo; Phillip W Beatty; Gwyn C Jones; Thilo Knoll; Melinda T Neri
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

3.  Use of and Self-Perceived Need for Assistive Devices in Individuals with Disabilities in Taiwan.

Authors:  Kwok-Tak Yeung; Chung-Hui Lin; Ya-Ling Teng; Fen-Fen Chen; Shu-Zon Lou; Chiung-Ling Chen
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.